On computational classification of genetic cardiac diseases applying iPSC cardiomyocytes

Martti Juhola1, Henry Joutsijoki1, Kirsi Penttinen2

  • 1Faculty of Information Technology and Communication Sciences, Tampere University, 33014 Finland.

Insights

Machine learning effectively classifies genetic cardiac diseases using calcium transient data from human induced pluripotent stem cells (iPSC-CMs). This approach accurately distinguishes between healthy controls and various genetic heart conditions.

Area of Science:

  • Biomedical Engineering
  • Cardiology
  • Computational Biology

Background:

  • Human induced pluripotent stem cells (iPSC-CMs) offer a model for studying genetic cardiac diseases.
  • Abnormal calcium transients in cardiomyocytes are linked to impaired contractility and arrhythmias in genetic heart conditions.
  • Existing research utilizes iPSC-CMs and machine learning for disease classification.

Purpose of the Study:

  • To classify genetic cardiac diseases using calcium (Ca2+) transient data and machine learning algorithms.
  • To extend previous findings by including data from two additional genetic heart diseases: dilated cardiomyopathy and Long QT Syndrome 2.
  • To compare classification accuracies using leave-one-out versus 10-fold cross-validation methods.

Main Methods:

  • Calcium transients were measured from disease-specific iPSC-CMs.
  • Machine learning algorithms were applied to peak attributes of calcium transient signals.
  • Classification was performed to differentiate between various genetic cardiac diseases and healthy controls.

Main Results:

  • The study successfully extended disease classification to include dilated cardiomyopathy and Long QT Syndrome 2.
  • Machine learning models achieved good classification accuracies despite increased complexity and number of diseases.
  • Leave-one-out and 10-fold cross-validation yielded comparable classification results.

Conclusions:

  • Accurate classification of multiple genetic cardiac diseases is achievable using iPSC-CM calcium transient data and machine learning.
  • The study validates the utility of iPSC-CMs as a model for understanding disease mechanisms.
  • Both leave-one-out and 10-fold cross-validation are reliable methods for assessing model performance in this context.
Abstract

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
129